FDA Commissioner Makary Resigns 2026: What It Means for Drug Approvals, Abortion Access, and the Food Supply

# FDA Commissioner Makary Resigns 2026: What It Means for Drug Approvals, Abortion Access, and the Food Supply

> **Quick answer:** FDA Commissioner Marty Makary resigned on May 12, 2026, after 13 months in office. He was pushed out following clashes with the Trump administration over flavored e-cigarette approvals, slow-walking a mifepristone safety review demanded by anti-abortion groups, and a staff morale collapse driven by mass layoffs of career scientists. Kyle Diamantas, the agency's deputy commissioner for food, is now acting commissioner. Drug approval timelines, abortion pill access, and food safety oversight all face a period of significant uncertainty.

FDA Commissioner Marty Makary resigns 2026 — and the departure leaves the country's top drug and food regulator without confirmed permanent leadership at one of the most consequential moments in modern public health. Here is everything you need to know about why he left, who is now in charge, and what it means for you.

*This article is for informational purposes only and does not replace professional medical advice. Consult a healthcare provider for medical concerns.*

## Why Marty Makary Resigned as FDA Commissioner

Makary's 13-month tenure unraveled under pressure from multiple directions simultaneously — a rare scenario in which the White House, industry, anti-abortion activists, and career FDA staff all lost confidence in him at the same time.